PIRS - Pieris Pharmaceuticals GAAP EPS of -$0.18 misses by $0.04 revenue of $1.94M misses by $4.57M
2023-05-10 07:11:28 ET
- Pieris Pharmaceuticals press release ( NASDAQ: PIRS ): Q1 GAAP EPS of -$0.18 misses by $0.04 .
- Revenue of $1.94M (-82.3% Y/Y) misses by $4.57M .
For further details see:
Pieris Pharmaceuticals GAAP EPS of -$0.18 misses by $0.04, revenue of $1.94M misses by $4.57M